Dozens of independent laboratory tests have shown WellAir portable air disinfection units to be effective

Highly infectious viruses and bacteria like COVID-19, influenza, norovirus, measles, MRSA and C.diff spread through the air. While large droplets fall to surfaces, small droplets can stay airborne indefinitely.

WellAir portable air disinfection units use NanoStrike™, a patented nanotechnology that safely and effectively inactivates harmful airborne microorganisms at the molecular level.

Watch the video to learn more about NanoStrike technology.

More than 25 laboratory and clinical studies have shown the WellAir portable air disinfection units:

  • Reduce pathogens in the air that lead to viral and bacterial infection, including SARS-CoV-2 (The NV1050 was shown to reduce live SARS-CoV-2, the virus causing COVID-19, by 99.99% in 30 minutes.)
  • Reduce total VOCs that cause odor, headaches and eye and throat irritation
  • Reduce dust, mold spores and pollen that trigger asthma and allergies

View some of the results below:

SARS-Reduction

SARS-CoV-2 Reduction

The NV1050 was shown to reduce live SARS-CoV-2, the virus causing COVID-19, by 99.99% in 30 minutes.

Measles Reduction

Measles Virus Reduction

The results achieved during the testing show that the NV1050 was able to reduce the concentration of HPIV3 by 99.87% in 20 – 30 minutes.

Influenza Reduction

Influenza A Reduction

The NV1050 was effective in reducing airborne Influenza A aerosols in the test chamber, reaching 99.9% airborne virus reduction within the first 10 – 20 minutes of operation at max speed.

Tuberculosis Reduction

Tuberculosis Reduction

The results achieved during the testing show that the NV1050 was able to reduce the concentration of M. smegmatis, a surrogate for Mycobacterium tuberculosis, artificially aerosolized by 95% within the first 15 minutes and this rose to 97% after 30 minutes of A/C operation.

MRSA Reduction

MRSA Reduction

The NV1050 achieved a microbial cell reduction of 99.94% of Staphylococcus epidermidis, a surrogate for methicillin-resistant Staphylococcus aureus (MRSA), within 15 minutes of operation.

C.Diff_Reduction

C. difficile Reduction

The NV1050 demonstrated to be effective in reducing the airborne C. difficile by 99.6% within the first 20 minutes and this increased to > 99.9% after 40 minutes.

Click here to download a summary of laboratory research results.

Three Sizes Available

Used in more than 450 healthcare facilities, WellAir portable air disinfection units are available in three sizes to accommodate any space including

  • Protect Range (NV200): Reception desk areas, bathrooms and supply rooms
  • Protect Range (NV900): Exam rooms, patient rooms, break rooms and nurses stations
  • Defend Range (NV1050): Emergency rooms, operating theatres and intensive care units (NV1050 cleared by FDA as 510(k) Class II Medical Device)

For more information about WellAir Portable Air Disinfection Units, call 888-891-1200 or email us to be connected to a local representative.

MED Alliance Group is an ISO 13485 certified medical device distributor and has been dedicated to meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, as well as NICU and PICU.

Please follow us on LinkedIn, Facebook and Twitter for MED Alliance product updates.